revenue from raw material and By-product increased by Baht 1,672.27 or 9,883.39%, from sales of raw materials for a produce biodiesel to the customers in the same industry. However, the Company will only
was increased by 42.06% and total sales of Edible oil increased by 55.81% from 3rd quarter of 2020. Currently, Company only sells to some industrial customers and chained restaurants who were affected
quarters of 2019, while on the downside we experience increased competitive pressure on our markets. This we plan to overcome with our efficient fixed cost base and continued focus on quality while widening
increased by 22.72 percent for the separate financial statements, and the revenue from sales – net increased by 24.92 percent for the consolidated financial statements. This was caused by the late of 2nd
million in 2Q2018, increased by THB 129.92 million or 120.60% up comparing to 2Q2017. In addition, the consolidated EBITDA in 2Q2018 was THB 631.26 million, decreased by THB 238.21 million or 27.40% down
income totaling Baht 47.79 million was mainly affected by the discontinue of profits from sale of investment assets which had occurred only in the year 2018. Nevertheless, Asia Medical & Agricultural
. It was decreased in line with sales decrease and transfers of ownership. Gross profit margin ( Only sales of real estate) The Company and its subsidiaries had gross profit margin for the first quarter
phases. In which phase 1 is a condominium ready for sale remaining awaiting transfer of ownership, only 17% of the total amount. Phase 2 is still under development. Forest Patong Project, Phuket is under
which phase 1 is a condominium ready for sale remaining awaiting transfer of ownership, only 13% of the total amount. Phase 2 is still under development. Forest Patong Project, Phuket is under the
-month period ended 30 June 2018 and 2019 were THB 0.00 and 45.13 million, respectively. Revenue from construction service had increased significantly due to the expansion of construction business by